
Alex J Mitchell
NHS consultant and honorary senior lecturer in psycho-oncology (a branch of liaison psychiatry). Main interests evidence base for diagnosis of mental illness (incl screening), mood disorders, quality of care, cognitive impairment.
I try to conduct clinically relevant mental health research that produces a meaningful answer. If you are interested in collaboration with me or need help analyzing data from diagnostic studies, please get in touch ([email protected])
List of research interests: depression, quality of care, inequalities, clinician judgement, diagnosis, accuracy, validity, screening, scales and tools, MCI, dementia, primary care, physical illness, anxiety, diagnostic tools, meta-analysis, adherence and compliance, mortality, diabetes and metabolic syndrome, physical examination, neuropsychiatry, psychometrics, distress and others.
Publication CV can be downloaded below (left hand margin)
Abbreviated publication list (with links): http://publicationslist.org/alex.j.mitchell
Previous Research Collaborators
N Agrawal, Z Al-salihy, J Arcelus, E Baker-Glenn (3), J Bauer, J Benito-León (10), I Bennett, F Bermejo-Pareja (4), S Beyenburg, H Bhatti, P Bidstrup (2), V Bird (3), J Cacho, L Carlson (2), G Carter, M Chan, A Chapman, I Chelminski, C Chew-Graham, J Chiong, K Clover, A Coco, C Coggan (2), C Correll (3), J Coyne (6), H Crimlisk, D Crowfoot, D Culpan, S Dalton, E Davies, V Delaffon, I Deltour, T Dening, M Dennis, T Dinan, C Doebbeling, C Elger (3), C Eze-Nliam, S Fabbri, C Fayard, B Fernández-Calvo, N Frasure-Smith, T Friedman, R García-García, D Goldberg, J González, P Goulding, L Grainger (2), L Granger (3), L Grassi (2), R Grünewald, R Gärtner, M Haddad, M Halton, H Hampel, J Herdman, M De Hert (5), S Hooley, M Horst, S Howlett (2), S Hughes (2), N Hussain, K Ibrahim (2), C Johansen (4), E Johnson, P de Jonge, S Kaar, V Kakkadasam, H Kehlet, S Kemp, D Kessler, J Knapen, N Kroman, S Kumar (2), D Lawrence, J Leaver, B Lima, W Linden, K Lord (4), O Lord (2), M Loscalzo, E Louis (3), K Magruder, M Mahmud, S Malladi (2), D Malone (3), P Manu, J McGlinchey, N Meader (7), V Mercken, B Mertz, A Mitchell (114), J Monge-Argilés, J Morales-Gonzáles, J Morales-González (2), J Morgan, A Muhyaldin, H Möller, C Newton, J Nicholson, S Nielsen, P Nirodi, M Nutman, J Packham, B Park (2), R Patel, M Pentzek, D Petersen, J Peuskens, M Pickard, S Pilling, I Posada (2), M Probst, R Pukrop, T Rahim, S Rao (4), S Ratcliffe, M Reuber (4), J Rivera-Navarro (4), M Rizzo (3), N Rottmann, N Rudd (2), A de Santiago, D Schmidt, T Selmes, M Shiri-Feshki (2), J Slattery, A Smith, C Smith, K Soderlund, J Spencer, L Stoletniy, H Subramaniam (2), K Sweers (3), P Symonds (9), Á Sánchez-Ferro (2), J Sánchez-Paya, S Teipel, B Thombs (2), R Trincado (2), A Vahabzadeh, D Vancampfort (4), A Vaze (4), S Vega, J Vicente-Villardón, A Villarejo (2), J Wales, A Waller, M Wampers, M Whooley, R van Winkel (3), D Young, W Yu (2), J Zabora, R Ziegelstein, M Zimmerman, M Zuidersma
Phone: 0116 2954562
Address: University of Leicester
Dept Cancer Studies
I try to conduct clinically relevant mental health research that produces a meaningful answer. If you are interested in collaboration with me or need help analyzing data from diagnostic studies, please get in touch ([email protected])
List of research interests: depression, quality of care, inequalities, clinician judgement, diagnosis, accuracy, validity, screening, scales and tools, MCI, dementia, primary care, physical illness, anxiety, diagnostic tools, meta-analysis, adherence and compliance, mortality, diabetes and metabolic syndrome, physical examination, neuropsychiatry, psychometrics, distress and others.
Publication CV can be downloaded below (left hand margin)
Abbreviated publication list (with links): http://publicationslist.org/alex.j.mitchell
Previous Research Collaborators
N Agrawal, Z Al-salihy, J Arcelus, E Baker-Glenn (3), J Bauer, J Benito-León (10), I Bennett, F Bermejo-Pareja (4), S Beyenburg, H Bhatti, P Bidstrup (2), V Bird (3), J Cacho, L Carlson (2), G Carter, M Chan, A Chapman, I Chelminski, C Chew-Graham, J Chiong, K Clover, A Coco, C Coggan (2), C Correll (3), J Coyne (6), H Crimlisk, D Crowfoot, D Culpan, S Dalton, E Davies, V Delaffon, I Deltour, T Dening, M Dennis, T Dinan, C Doebbeling, C Elger (3), C Eze-Nliam, S Fabbri, C Fayard, B Fernández-Calvo, N Frasure-Smith, T Friedman, R García-García, D Goldberg, J González, P Goulding, L Grainger (2), L Granger (3), L Grassi (2), R Grünewald, R Gärtner, M Haddad, M Halton, H Hampel, J Herdman, M De Hert (5), S Hooley, M Horst, S Howlett (2), S Hughes (2), N Hussain, K Ibrahim (2), C Johansen (4), E Johnson, P de Jonge, S Kaar, V Kakkadasam, H Kehlet, S Kemp, D Kessler, J Knapen, N Kroman, S Kumar (2), D Lawrence, J Leaver, B Lima, W Linden, K Lord (4), O Lord (2), M Loscalzo, E Louis (3), K Magruder, M Mahmud, S Malladi (2), D Malone (3), P Manu, J McGlinchey, N Meader (7), V Mercken, B Mertz, A Mitchell (114), J Monge-Argilés, J Morales-Gonzáles, J Morales-González (2), J Morgan, A Muhyaldin, H Möller, C Newton, J Nicholson, S Nielsen, P Nirodi, M Nutman, J Packham, B Park (2), R Patel, M Pentzek, D Petersen, J Peuskens, M Pickard, S Pilling, I Posada (2), M Probst, R Pukrop, T Rahim, S Rao (4), S Ratcliffe, M Reuber (4), J Rivera-Navarro (4), M Rizzo (3), N Rottmann, N Rudd (2), A de Santiago, D Schmidt, T Selmes, M Shiri-Feshki (2), J Slattery, A Smith, C Smith, K Soderlund, J Spencer, L Stoletniy, H Subramaniam (2), K Sweers (3), P Symonds (9), Á Sánchez-Ferro (2), J Sánchez-Paya, S Teipel, B Thombs (2), R Trincado (2), A Vahabzadeh, D Vancampfort (4), A Vaze (4), S Vega, J Vicente-Villardón, A Villarejo (2), J Wales, A Waller, M Wampers, M Whooley, R van Winkel (3), D Young, W Yu (2), J Zabora, R Ziegelstein, M Zimmerman, M Zuidersma
Phone: 0116 2954562
Address: University of Leicester
Dept Cancer Studies
less
Related Authors
Debra Kaysen
Stanford University
James A. Coan
University of Virginia
Steven Pinker
Harvard University
Vivekanand Jha
Fortis Escorts Heart Institute
Joachim Sturmberg
Monash University
Matthew Broome
University of Oxford
John Barry
Queen's University Belfast
Mark van den Boogaard
Radboud University Nijmegen
Eric S . Kim (UBC)
University of British Columbia
Hugo Selma Sánchez
Universidad de la República
InterestsView All (31)
Uploads
Books by Alex J Mitchell
Edition: 1st edition
Format: Paperback
Dimensions: 8.3 x 5.1 x 0.4 inches
Weight: 12.2 ounces
ISBN 10: 075064088X
ISBN 13: 9780750640886
Subject: Psychiatry
Psychiatry (General)
Medical
Psychology
General
Psychiatry - General
Medical / Psychiatry
Genetics
Study guides, home study & revision notes
Handbooks, manuals, etc
Neurosciences
Papers by Alex J Mitchell
Active Surveillance (AS) is recommended for the treatment of localised prostate cancer; however this option may be under-used, at least in part because of expectations of psychological adverse events in those offered or accepting AS.
Objective
(1) Determine the impact on psychological wellbeing when treated with AS (non-comparative studies). (2) Compare AS with active treatments for the impact on psychological wellbeing (comparative studies).
Method
We used the PRISMA guidelines and searched Medline, PsychInfo, EMBASE, CINHAL, Web of Science, Cochrane Library and Scopus for articles published January 2000–2014. Eligible studies reported original quantitative data on any measures of psychological wellbeing.
Results
We identified 34 eligible articles (n = 12,497 individuals); 24 observational, eight RCTs, and two other interventional studies. Studies came from North America (16), Europe (14) Australia (3) and North America/Europe (1). A minority (5/34) were rated as high quality. Most (26/34) used validated instruments, whilst a substantial minority (14/34) used watchful waiting or no active treatment rather than Active Surveillance. There was modest evidence of no adverse impact on psychological wellbeing associated with Active Surveillance; and no differences in psychological wellbeing compared to active treatments.
Conclusion
Patients can be informed that Active Surveillance involves no greater threat to their psychological wellbeing as part of the informed consent process, and clinicians need not limit access to Active Surveillance based on an expectation of adverse impacts on psychological wellbeing.
Edition: 1st edition
Format: Paperback
Dimensions: 8.3 x 5.1 x 0.4 inches
Weight: 12.2 ounces
ISBN 10: 075064088X
ISBN 13: 9780750640886
Subject: Psychiatry
Psychiatry (General)
Medical
Psychology
General
Psychiatry - General
Medical / Psychiatry
Genetics
Study guides, home study & revision notes
Handbooks, manuals, etc
Neurosciences
Active Surveillance (AS) is recommended for the treatment of localised prostate cancer; however this option may be under-used, at least in part because of expectations of psychological adverse events in those offered or accepting AS.
Objective
(1) Determine the impact on psychological wellbeing when treated with AS (non-comparative studies). (2) Compare AS with active treatments for the impact on psychological wellbeing (comparative studies).
Method
We used the PRISMA guidelines and searched Medline, PsychInfo, EMBASE, CINHAL, Web of Science, Cochrane Library and Scopus for articles published January 2000–2014. Eligible studies reported original quantitative data on any measures of psychological wellbeing.
Results
We identified 34 eligible articles (n = 12,497 individuals); 24 observational, eight RCTs, and two other interventional studies. Studies came from North America (16), Europe (14) Australia (3) and North America/Europe (1). A minority (5/34) were rated as high quality. Most (26/34) used validated instruments, whilst a substantial minority (14/34) used watchful waiting or no active treatment rather than Active Surveillance. There was modest evidence of no adverse impact on psychological wellbeing associated with Active Surveillance; and no differences in psychological wellbeing compared to active treatments.
Conclusion
Patients can be informed that Active Surveillance involves no greater threat to their psychological wellbeing as part of the informed consent process, and clinicians need not limit access to Active Surveillance based on an expectation of adverse impacts on psychological wellbeing.
This is a behind the scences overview of the NHS clinical excellent awards scheme. First published online only October 2008. Comments welcome